ZA919219B - Analytical markers for malignant breast cancer - Google Patents

Analytical markers for malignant breast cancer

Info

Publication number
ZA919219B
ZA919219B ZA919219A ZA919219A ZA919219B ZA 919219 B ZA919219 B ZA 919219B ZA 919219 A ZA919219 A ZA 919219A ZA 919219 A ZA919219 A ZA 919219A ZA 919219 B ZA919219 B ZA 919219B
Authority
ZA
South Africa
Prior art keywords
breast cancer
malignant breast
marker
analytical markers
markers
Prior art date
Application number
ZA919219A
Other languages
English (en)
Inventor
Paul Basset
Basset Paul
Jean-Pierre Bellocq
Bellocq Jean-Pierre
Piere Chambon
Chambon Piere
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Publication of ZA919219B publication Critical patent/ZA919219B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA919219A 1990-11-21 1991-11-21 Analytical markers for malignant breast cancer ZA919219B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9025326A GB2250993B (en) 1990-11-21 1990-11-21 Stromelysin-3 and its application in the diagnosis and treatment of malignant breast cancer

Publications (1)

Publication Number Publication Date
ZA919219B true ZA919219B (en) 1992-10-28

Family

ID=10685753

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919219A ZA919219B (en) 1990-11-21 1991-11-21 Analytical markers for malignant breast cancer

Country Status (16)

Country Link
US (1) US5236844A (da)
EP (1) EP0513316B1 (da)
JP (1) JP3516448B2 (da)
AT (1) ATE152179T1 (da)
CA (1) CA2073860A1 (da)
DE (1) DE69125824T2 (da)
DK (1) DK0513316T3 (da)
ES (1) ES2101079T3 (da)
GB (1) GB2250993B (da)
GR (1) GR3023560T3 (da)
HU (1) HU215165B (da)
IE (1) IE914056A1 (da)
NZ (2) NZ240688A (da)
PT (1) PT99562B (da)
WO (1) WO1992009701A1 (da)
ZA (1) ZA919219B (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2150125A1 (en) * 1992-11-25 1994-06-09 Timothy R. Billiar Cdna clone for human inducible nitric oxide synthase and process for preparing same
WO1995003428A1 (en) * 1993-07-20 1995-02-02 University Of Massachusetts Medical Center In vivo nucleic acid hybridization method
JPH07303482A (ja) 1993-11-30 1995-11-21 Fuji Yakuhin Kogyo Kk 新規なメタロプロテアーゼおよびそれをコードするｄｎａ
US6825024B1 (en) 1993-11-30 2004-11-30 Fuji Yakuhin Kogyo Kabushiki Kaisha Metalloproteinase and encoding DNA therefor
WO1995015374A1 (fr) * 1993-11-30 1995-06-08 Fuji Yakuhin Kogyo Kabushiki Kaisha Nouvelle metalloprotease et adn codant pour cette derniere
US5710001A (en) * 1994-08-12 1998-01-20 Myriad Genetics, Inc. 17q-linked breast and ovarian cancer susceptibility gene
US5747282A (en) * 1994-08-12 1998-05-05 Myraid Genetics, Inc. 17Q-linked breast and ovarian cancer susceptibility gene
US5753441A (en) * 1994-08-12 1998-05-19 Myriad Genetics, Inc. 170-linked breast and ovarian cancer susceptibility gene
US5709999A (en) * 1994-08-12 1998-01-20 Myriad Genetics Inc. Linked breast and ovarian cancer susceptibility gene
US5763415A (en) 1995-08-03 1998-06-09 John Hopkins University School Of Medicine Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer
US5883241A (en) * 1995-09-05 1999-03-16 Celltech Therapeutics Limited DNA sequences coding for a human metalloproteinase and variants thereof
US5905027A (en) * 1995-12-27 1999-05-18 Uab Research Foundation Method of diagnosing and treating gliomas
EP0897426B1 (en) * 1996-04-25 2006-06-28 Takeda Pharmaceutical Company Limited Matrix metalloprotease
US20050153373A1 (en) * 1996-10-31 2005-07-14 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
DE69737788T2 (de) * 1996-10-31 2008-03-13 Abbott Laboratories, Abbott Park Reagenzien und methoden zum nachweis von erkrankungen der brust
US20050202499A1 (en) 1996-10-31 2005-09-15 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
US20030165971A1 (en) * 1996-10-31 2003-09-04 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
CA2273847C (en) * 1996-12-06 2013-08-13 Urocor, Inc. Diagnosis of disease state using mrna profiles
WO1998040475A1 (en) 1997-03-11 1998-09-17 Abbott Laboratories Human matrix metalloprotease gene, proteins encoded therefrom and methods of using same
EP0969868A2 (en) * 1997-03-18 2000-01-12 Ortho-Mcneil Pharmaceutical, Inc. Methods and kits for treating and diagnosing leiomyomas
US6190857B1 (en) 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
US7332270B1 (en) 1997-03-24 2008-02-19 Urocor, Inc. Diagnosis of disease state using mRNA profiles in peripheral leukocytes
US20040072210A1 (en) * 1997-07-07 2004-04-15 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
WO1999002714A1 (en) * 1997-07-07 1999-01-21 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
EP1032689A1 (en) * 1997-11-17 2000-09-06 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US5972615A (en) * 1998-01-21 1999-10-26 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
US6600057B2 (en) 2000-12-29 2003-07-29 Kimberly-Clark Worldwide, Inc. Matrix metalloproteinase inhibitors
US7041787B2 (en) * 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
EP1414954A2 (en) * 2001-07-09 2004-05-06 Kobenhavns Universitet Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer
US20030119073A1 (en) * 2001-12-21 2003-06-26 Stephen Quirk Sensors and methods of detection for proteinase enzymes
DE10217254A1 (de) * 2002-04-15 2003-10-23 Proteosys Ag Verwendung von Substanzen zur Behandlung von Tumoren
US20060088899A1 (en) * 2002-05-31 2006-04-27 Alvarez Vernon L Combination chemotherapy with chlorotoxin
US20050193432A1 (en) * 2003-11-18 2005-09-01 Whitehead Institute For Biomedical Research Xenograft model of functional normal and malignant human breast tissues in rodents and methods thereof
US7667001B1 (en) * 2004-01-27 2010-02-23 Compugen Ltd. Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
US7569662B2 (en) * 2004-01-27 2009-08-04 Compugen Ltd Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
WO2006130472A2 (en) * 2005-05-27 2006-12-07 The Regents Of The University Of California Identification of rac1b as a marker and mediator of matrix metalloproteinase-induced malignancy
BRPI0912683A2 (pt) 2008-05-15 2016-01-26 Transmolecular Inc tratamento de tumores metastáticos
CN102844044B (zh) 2010-02-04 2016-10-26 摩尔弗泰克有限公司 氯毒素多肽和结合物及其应用
EP2569330B1 (en) 2010-05-11 2016-09-28 Fred Hutchinson Cancer Research Center Chlorotoxin variants, conjugates, and methods for their use
KR101313184B1 (ko) * 2010-06-24 2013-09-30 한국표준과학연구원 질병 지표 검출 키트 및 질병 지표 검출 방법
AU2013359429A1 (en) 2012-12-10 2015-07-09 Fred Hutchinson Cancer Research Center Methods for screening
US11559580B1 (en) 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof
CA3021011A1 (en) 2016-04-15 2017-10-19 Blaze Bioscience, Inc. Methods of treating breast cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63503514A (ja) * 1986-06-17 1988-12-22 セルテク・リミテツド タンパク質の製法

Also Published As

Publication number Publication date
GB9025326D0 (en) 1991-01-02
HU215165B (hu) 1998-10-28
HU9202368D0 (en) 1992-10-28
PT99562B (pt) 1999-04-30
ES2101079T3 (es) 1997-07-01
JP3516448B2 (ja) 2004-04-05
US5236844A (en) 1993-08-17
WO1992009701A1 (fr) 1992-06-11
NZ240688A (en) 1994-09-27
IE914056A1 (en) 1992-06-03
NZ260705A (en) 1997-05-26
DK0513316T3 (da) 1997-05-20
JPH05505530A (ja) 1993-08-19
AU646914B2 (en) 1994-03-10
HUT65373A (en) 1994-05-02
EP0513316B1 (fr) 1997-04-23
GB2250993A (en) 1992-06-24
DE69125824T2 (de) 1997-08-07
GR3023560T3 (en) 1997-08-29
EP0513316A1 (fr) 1992-11-19
ATE152179T1 (de) 1997-05-15
PT99562A (pt) 1992-10-30
AU9089691A (en) 1992-06-25
DE69125824D1 (de) 1997-05-28
GB2250993B (en) 1995-02-15
CA2073860A1 (en) 1992-05-22

Similar Documents

Publication Publication Date Title
ZA919219B (en) Analytical markers for malignant breast cancer
MX9804009A (es) Inhibicion de crecimiento tumoral por oligonucleotidos de antisentido para il-8 y receptor de il-8.
IL254264A (en) Doses for treatments using anti-erbb2 antibodies
DE69940264D1 (de) Krebsantigene, basierend auf dem tumorunterdrückenden genprodukt wt1
WO2000055180A3 (en) Human lung cancer associated gene sequences and polypeptides
EP1468014A4 (en) COMPOSITIONS AND METHODS FOR WT1-SPECIFIC IMMUNOTHERAPY
ES8704005A1 (es) Un metodo para evaluar la probabilidad de malignidad celular en una muestra biologica de un haspedante humano.
WO2003058201A3 (en) Methods for identifying marker genes for cancer
GR3026219T3 (en) Mouse monoclonal antibodies
ATE332979T1 (de) Detektion von änderungen von tumor-suppressor genen zur diagnose von krebs
WO2001018046A3 (en) Ovarian tumor sequences and methods of use therefor
EP1326996A4 (en) ID-1 AND ID-2 GENES AND PRODUCTS AS DIAGNOSTIC OR PROGNOSTIC MARKERS AND THERAPEUTIC TARGETS FOR THE TREATMENT OF BREAST CANCER AND OTHER TYPES OF CARCINOMA
GR3021876T3 (en) Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours.
IL207012A0 (en) Diagnosis and therapy of cancer using sgp28-related molecules
BR0215689A (pt) Composição farmacêutica compreendendo arsênico para o tratamento de malignidade
EP1438388A4 (en) IBC-1 (INVASIVE-1 BREAST CANCER), ONCOGEN PRESUME AMPLIFIED IN BREAST CANCER
DE69427533D1 (de) Ein extrakt aus muscheln, extraktionsmethoden und verwendungen davon
WO2003038113A3 (en) Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
SU1032745A1 (ru) 3-тиосемикарбазон-1,1-дифенилиндандиона, повышающий физическую выносливость
WO2000044889A3 (de) Säugetier mit induzierbarem duktalen karzinom in situ
WO2000059934A3 (en) Testis specific protein
ATE95062T1 (de) Zusammensetzung zur behandlung von krebs, gekennzeichnet durch ueberexpression des c-fmsproto-onkogens.
WO2003038400A3 (en) Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 54394